Catalio Capital Management, LP Quant / Systematic

CIK: 0001958125 · Show all filings

Period: Q4 2025 (← Previous)

Filing Date: Feb 17, 2026

Total Value ($000): $565,790 (100.0% shares, 0.0% debt)

Holdings (45)

New Positions (14)

Decreased Positions (20)

ISRG INTUITIVE SURGICAL INC 2.7%
Value ($000) $15,410 (-51.7%) Shares 27,209 (-61.9%) Est. Cost $513.00 Unrealized +3.8%
LLY ELI LILLY & CO 4.9%
Value ($000) $27,859 (-36.4%) Shares 25,923 (-54.8%) Est. Cost $793.52 Unrealized +20.4%
SLNO SOLENO THERAPEUTICS INC 2.9%
Value ($000) $16,684 (-41.0%) Shares 360,340 (-13.8%) Est. Cost $64.77 Unrealized -15.3%
NTRA NATERA INC 2.5%
Value ($000) $14,266 (-40.3%) Shares 62,273 (-58.0%) Est. Cost $156.65 Unrealized +33.2%
CYTK CYTOKINETICS INC 2.9%
Value ($000) $16,418 (-33.9%) Shares 258,381 (-42.8%) Est. Cost $50.21 Unrealized +23.9%
GRAL GRAIL INC 0.5%
Value ($000) $2,594 (-68.2%) Shares 30,313 (-78.0%) Est. Cost $38.21 Unrealized +126.1%
IRON DISC MEDICINE INC 1.5%
Value ($000) $8,769 (-38.7%) Shares 110,427 (-49.0%) Est. Cost $57.71 Unrealized +46.4%
RARE ULTRAGENYX PHARMACEUTICAL IN 0.7%
Value ($000) $3,739 (-57.3%) Shares 162,550 (-44.2%) Est. Cost $34.43 Unrealized -4.5%
ASND ASCENDIS PHARMA A/S 4.5%
Value ($000) $25,432 (-11.8%) Shares 119,265 (-17.7%) Est. Cost $137.67 Unrealized
REGN REGENERON PHARMACEUTICALS 4.1%
Value ($000) $22,999 (+15.7%) Shares 29,797 (-15.7%) Est. Cost $564.28 Unrealized +20.3%
PHAT PHATHOM PHARMACEUTICALS INC 2.0%
Value ($000) $11,596 (-12.7%) Shares 698,996 (-38.1%) Est. Cost $7.47 Unrealized +91.2%
TARA PROTARA THERAPEUTICS INC 1.4%
Value ($000) $7,709 (+18.1%) Shares 1,446,254 (-3.6%) Est. Cost $3.30 Unrealized +68.3%
SUPN SUPERNUS PHARMACEUTICALS INC 2.3%
Value ($000) $12,796 (-6.7%) Shares 257,465 (-10.3%) Est. Cost $40.27 Unrealized +20.7%
DNTH DIANTHUS THERAPEUTICS INC 4.8%
Value ($000) $26,934 (+2.5%) Shares 653,572 (-2.1%) Est. Cost $25.71 Unrealized +50.8%
GPCR STRUCTURE THERAPEUTICS INC 3.1%
Value ($000) $17,589 (-3.6%) Shares 252,901 (-61.2%) Est. Cost $25.23 Unrealized
ABVX ABIVAX SA 2.3%
Value ($000) $13,285 (-3.5%) Shares 98,514 (-39.2%) Est. Cost $84.90 Unrealized
PVLA PALVELLA THERAPEUTICS INC NE 0.2%
Value ($000) $1,094 (+45.3%) Shares 10,452 (-13.0%) Est. Cost $44.59 Unrealized +91.3%
SNDX SYNDAX PHARMACEUTICALS INC 4.4%
Value ($000) $25,145 (+1.2%) Shares 1,196,807 (-25.9%) Est. Cost $13.56 Unrealized +28.7%
ADMA ADMA BIOLOGICS INC 1.8%
Value ($000) $10,296 (+2.6%) Shares 564,461 (-17.5%) Est. Cost $19.85 Unrealized -15.1%
ADPT ADAPTIVE BIOTECHNOLOGIES COR 2.4%
Value ($000) $13,336 (+0.7%) Shares 821,195 (-7.2%) Est. Cost $8.47 Unrealized +92.7%